This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. Its structure, featuring a nitro group and a dibenzoazepine core, makes it a valuable intermediate in the creation of compounds targeting neurological disorders. Researchers explore its potential in designing drugs for conditions like anxiety, depression, and epilepsy due to its interaction with neurotransmitter systems. Additionally, its nitro group can be reduced to an amine, enabling further chemical modifications to enhance drug efficacy and specificity. Its application is largely confined to laboratory settings, where it aids in the discovery and optimization of new medicinal compounds.